Salah-eddin E. Batran-Al - Publications

Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).

Journal: JAMA oncology

Published: July 09, 2026

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

Journal: Nature communications

Published: April 17, 2026

The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 13, 2026

FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 03, 2026

Safety and Preliminary Activity of Neoadjuvant Trastuzumab Deruxtecan plus 5-Fluorouracil and Folinic Acid for HER2-Positive, Resectable Esophagogastric Adenocarcinoma: Results from the Safety Run-In Cohort of the Phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART Trial.

Journal: Oncology research and treatment

Published: March 02, 2026

Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 28, 2025

Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 13, 2025

Response to the Letter to the Editor-"Beyond safety: Reassessing autonomy, infection risk, and long-term value of multi-chamber parenteral nutrition in cancer care".

Journal: Clinical nutrition ESPEN

Published: August 29, 2025

Response to the Letter to the Editor: Critical appraisal of the IKF-010 trial.

Journal: Clinical nutrition ESPEN

Published: August 11, 2025

Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial.

Journal: Nature medicine

Published: July 25, 2025

Exome sequencing points to pathogenic ATM variants in gastric cancer.

Journal: European journal of human genetics : EJHG

Published: July 04, 2025

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial.

Journal: Nature communications

Published: July 01, 2025